Live-cell imaging of cell-to-cell variability in caspase-8 FRET reporter activity and cell fate trajectory modeling - Dataset (ID:20232)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein | Protein Concentration | Protein Conc Unit | Antibody Name | Antibody Concentration | Antibody Conc Unit | 2nd Antibody Name | 2nd Antibody Concentration | 2nd Antibody Conc Unit | Replicate | Mean log10(k) (a.u.) | Mean tau (min) | Surviving Fraction | Classification Accuracy (theta_T) | Classification Accuracy (fate boundary) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HeLa ICRP | Apomab | 25.0 | nM | 4 | -6.67 | 260.1646 | 0.889 | 0.89300 | 0.83951 | |||||||||
| HeLa ICRP | TNF10 | 1.0 | ng/ml | 1 | -6.60 | 379.1667 | 0.958 | 0.95833 | 1.00000 | |||||||||
| HeLa ICRP | TNF10 | 1.0 | ng/ml | 3 | -6.59 | 286.3068 | 0.949 | 0.96591 | 0.89773 | |||||||||
| HeLa ICRP | Apomab | 25.0 | nM | 5 | -6.58 | 309.2188 | 0.901 | 0.90865 | 0.88462 | |||||||||
| HeLa ICRP | Navitoclax | 10 | uM | TNF10 | 1.0 | ng/ml | 2 | -6.56 | 276.5333 | 0.964 | 0.98667 | 0.87556 | ||||||
| HeLa ICRP | Apomab | 100.0 | nM | 3 | -6.54 | 273.3562 | 0.911 | 0.95205 | 0.84932 | |||||||||
| HeLa ICRP | Apomab | 25.0 | nM | 6 | -6.53 | 267.1805 | 0.838 | 0.85338 | 0.84962 | |||||||||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 3 | -6.52 | 286.1860 | 0.876 | 0.88410 | 0.86523 | ||||||
| HeLa ICRP | Apomab | 50.0 | nM | 2 | -6.48 | 250.9659 | 0.972 | 0.98864 | 0.80682 | |||||||||
| HeLa ICRP | Apomab | 25.0 | nM | 2 | -6.45 | 249.8519 | 0.956 | 0.97037 | 0.88148 | |||||||||
| HeLa ICRP | Navitoclax | 10 | uM | TNF10 | 1.0 | ng/ml | 1 | -6.45 | 316.4894 | 0.957 | 0.97872 | 0.82979 | ||||||
| HeLa ICRP | Apomab | 25.0 | nM | 1 | -6.44 | 211.4919 | 0.968 | 0.97581 | 0.75806 | |||||||||
| HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 1.0 | ng/ml | 1 | -6.43 | 491.0887 | 1.000 | 0.99194 | 0.96774 | ||||||
| HeLa ICRP | Apomab | 50.0 | nM | 1 | -6.39 | 285.0388 | 0.953 | 0.95349 | 0.85271 | |||||||||
| HeLa ICRP | Apomab | 25.0 | nM | 3 | -6.37 | 263.5100 | 0.877 | 0.87966 | 0.88252 | |||||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 3 | -6.35 | 445.1084 | 0.889 | 0.98103 | 0.88889 | ||||||
| HeLa ICRP | TNF10 | 1.0 | ng/ml | 2 | -6.34 | 245.6857 | 0.977 | 0.97714 | 0.86286 | |||||||||
| HeLa ICRP | Apomab | 200.0 | nM | 2 | -6.34 | 213.4375 | 0.929 | 0.94643 | 0.78571 | |||||||||
| HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 1.0 | ng/ml | 2 | -6.32 | 468.5230 | 0.965 | 0.99344 | 0.91028 | ||||||
| HeLa ICRP | Apomab | 100.0 | nM | 2 | -6.31 | 231.7647 | 0.971 | 0.98529 | 0.85294 | |||||||||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 5 | -6.31 | 302.5813 | 0.872 | 0.90672 | 0.84816 | ||||||
| HeLa ICRP | Apomab | 200.0 | nM | 1 | -6.25 | 250.2333 | 0.940 | 0.96667 | 0.85333 | |||||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 4 | -6.21 | 485.6552 | 0.814 | 0.97069 | 0.80517 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 1 | -6.20 | 481.7639 | 0.801 | 0.96817 | 0.78780 | ||||||
| HeLa ICRP | TNF10 | 5.0 | ng/ml | 3 | -6.20 | 283.4633 | 0.895 | 0.92202 | 0.90826 |